日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Baby formula

China's mums key to Nestle baby milk deal

(Agencies) Updated: 2012-04-25 11:19

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 日韩欧美小说 | 午夜国产精品视频 | 中文字幕在线视频网站 | theporn玉足脚交91 | 97超碰97| 毛片毛片女人毛片毛片 | 久久av资源 | 欧美黄色一级 | 亚洲欧美视频在线 | 欧美日韩精品在线 | 亚洲第一在线视频 | 午夜在线一区 | 97免费公开视频 | 成人午夜av| 黄色小视频免费观看 | 在线观看国产一区 | 一区在线播放 | 麻豆视频播放 | 国产一级视频在线 | 久在线视频 | 国产五月天婷婷 | 久久久免费av | 亚洲人成人一区二区在线观看 | 激情丁香六月 | 亚洲精品在线视频 | 中文字幕色站 | 国产黄色影视 | 日韩精品天堂 | 黄色片子免费看 | 欧美色交 | 欧美 中文字幕 | 成人精品综合 | 欧美精品免费在线 | jizzjizzjizz亚洲| 91麻豆精品国产91久久久久久 | 国产精品视频网站 | 操人视频在线观看 | 亚洲天堂日本 | 激情网色 | 欧美在线免费看 | 国产精品久久久久久久久久免费看 |